Article Text
Statistics from Altmetric.com
Commentary to: OpenUrlCrossRefPubMedWeb of Science.
Context
Atrial fibrillation (AF) is a common arrhythmia in clinical practice. The major complication of AF is thromboembolic stroke. Patients with AF have a fivefold higher risk of stroke and a twofold increase in mortality.1 As complete cure for AF is never certain, the aims of AF therapy are symptom relief and prevention of thromboembolic events. The latter can be managed by vitamin-K-antagonists (VKA), but is accompanied by several disadvantages including increased risk of bleeding and the need for monitoring with regular lab work. New oral anticoagulants (NOAC) regimens are simpler but are still …
Footnotes
Competing interests The Cardiology Department of St Antonius Hospital receives proctoring fees for training/educational services from Atritech/Boston Scientific.
Provenance and peer review Commissioned; internally peer reviewed.